NCT00027612View on ClinicalTrials.gov

Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2006

Study Completion Date

July 31, 2009

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

carmustine

IV

DRUG

irinotecan hydrochloride

IV

RADIATION

radiation therapy

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00027612 - Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter